370 related articles for article (PubMed ID: 18198821)
21. 6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist.
Tavares FX; Al-Barazanji KA; Bishop MJ; Britt CS; Carlton DL; Cooper JP; Feldman PL; Garrido DM; Goetz AS; Grizzle MK; Hertzog DL; Ignar DM; Lang DG; McIntyre MS; Ott RJ; Peat AJ; Zhou HQ
J Med Chem; 2006 Nov; 49(24):7108-18. PubMed ID: 17125263
[TBL] [Abstract][Full Text] [Related]
22. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
Tanrikulu Y; Proschak E; Werner T; Geppert T; Todoroff N; Klenner A; Kottke T; Sander K; Schneider E; Seifert R; Stark H; Clark T; Schneider G
ChemMedChem; 2009 May; 4(5):820-7. PubMed ID: 19343764
[TBL] [Abstract][Full Text] [Related]
23. Homology modeling of MCH1 receptor and validation by docking/scoring and protein-aligned CoMFA.
Abu-Hammad A; Zalloum WA; Zalloum H; Abu-Sheikha G; Taha MO
Eur J Med Chem; 2009 Jun; 44(6):2583-96. PubMed ID: 19250717
[TBL] [Abstract][Full Text] [Related]
24. Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor.
Salo OM; Raitio KH; Savinainen JR; Nevalainen T; Lahtela-Kakkonen M; Laitinen JT; Järvinen T; Poso A
J Med Chem; 2005 Nov; 48(23):7166-71. PubMed ID: 16279774
[TBL] [Abstract][Full Text] [Related]
25. A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.
Sanders MP; Roumen L; van der Horst E; Lane JR; Vischer HF; van Offenbeek J; de Vries H; Verhoeven S; Chow KY; Verkaar F; Beukers MW; McGuire R; Leurs R; Ijzerman AP; de Vlieg J; de Esch IJ; Zaman GJ; Klomp JP; Bender A; de Graaf C
J Med Chem; 2012 Jun; 55(11):5311-25. PubMed ID: 22563707
[TBL] [Abstract][Full Text] [Related]
26. Peptide interactions with G-protein coupled receptors.
Marshall GR
Biopolymers; 2001; 60(3):246-77. PubMed ID: 11774230
[TBL] [Abstract][Full Text] [Related]
27. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
[TBL] [Abstract][Full Text] [Related]
28. Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor.
Geldenhuys WJ; Kuzenko SR; Simmons MA
J Med Chem; 2010 Nov; 53(22):8080-8. PubMed ID: 21047106
[TBL] [Abstract][Full Text] [Related]
29. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
McBriar MD; Guzik H; Shapiro S; Paruchova J; Xu R; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'neill K; Spar BD; Weig B; Weston DJ; Farley C; Cook J
J Med Chem; 2006 Apr; 49(7):2294-310. PubMed ID: 16570926
[TBL] [Abstract][Full Text] [Related]
30. 4-Acylamino-and 4-ureidobenzamides as melanin-concentrating hormone (MCH) receptor 1 antagonists.
Receveur JM; Bjurling E; Ulven T; Little PB; Nørregaard PK; Högberg T
Bioorg Med Chem Lett; 2004 Oct; 14(20):5075-80. PubMed ID: 15380202
[TBL] [Abstract][Full Text] [Related]
31. GPCR structure-based virtual screening approach for CB2 antagonist search.
Chen JZ; Wang J; Xie XQ
J Chem Inf Model; 2007; 47(4):1626-37. PubMed ID: 17580929
[TBL] [Abstract][Full Text] [Related]
32. Discovery of tetralin ureas as potent melanin concentrating hormone 1 receptor antagonists.
Guo T; Gu H; Hobbs DW; Busler DE; Rokosz LL
Bioorg Med Chem Lett; 2007 Mar; 17(6):1718-21. PubMed ID: 17251014
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel serotonin 2C receptor ligands by sequential virtual screening.
Ahmed A; Choo H; Cho YS; Park WK; Pae AN
Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.
Ando M; Sekino E; Haga Y; Moriya M; Ito M; Ito J; Iwaasa H; Ishihara A; Kanatani A; Ohtake N
Bioorg Med Chem Lett; 2009 Sep; 19(17):5186-90. PubMed ID: 19632840
[TBL] [Abstract][Full Text] [Related]
35. Discovery of melanin-concentrating hormone receptor R1 antagonists using high-throughput synthesis.
Su J; McKittrick BA; Tang H; Czarniecki M; Greenlee WJ; Hawes BE; O'Neill K
Bioorg Med Chem; 2005 Mar; 13(5):1829-36. PubMed ID: 15698800
[TBL] [Abstract][Full Text] [Related]
36. Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents.
Cirauqui N; Schrey AK; Galiano S; Ceras J; Pérez-Silanes S; Aldana I; Monge A; Kühne R
Bioorg Med Chem; 2010 Nov; 18(21):7365-79. PubMed ID: 20932767
[TBL] [Abstract][Full Text] [Related]
37. The use of three-dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist.
Muchmore SW; Souers AJ; Akritopoulou-Zanze I
Chem Biol Drug Des; 2006 Feb; 67(2):174-6. PubMed ID: 16492165
[TBL] [Abstract][Full Text] [Related]
38. CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.
Berkhout TA; Blaney FE; Bridges AM; Cooper DG; Forbes IT; Gribble AD; Groot PH; Hardy A; Ife RJ; Kaur R; Moores KE; Shillito H; Willetts J; Witherington J
J Med Chem; 2003 Sep; 46(19):4070-86. PubMed ID: 12954060
[TBL] [Abstract][Full Text] [Related]
39. Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry.
Nowak M; Kołaczkowski M; Pawłowski M; Bojarski AJ
J Med Chem; 2006 Jan; 49(1):205-14. PubMed ID: 16392805
[TBL] [Abstract][Full Text] [Related]
40. Strategies for designing GPCR-focused libraries and screening sets.
Jimonet P; Jäger R
Curr Opin Drug Discov Devel; 2004 May; 7(3):325-33. PubMed ID: 15216936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
